Mirror-image Isomers Screening: Overcoming the Enzyme Barriers for the Development of Peptide and Oligonucleotide Therapeutics

LI Chong,SHEN Jie,LU WeiYue,LU WuYuan
DOI: https://doi.org/10.1360/032010-788
2011-01-01
Abstract:The enzyme barriers in vivo greatly limited the development of peptide and oligonucleotide therapeutics.The mirror-image isomers screening including mirror-image phage display and Spiegelmer technology can obtain biostable D-peptides and L-oligonuclotides with high specificity to their targets,thus will be a promising technology for the development of novel peptide and oligonucleotide drugs.This review will focus on the principle of mirror-image isomers screening and highlight recent developments of this technology in the field of pharmaceutical research.
What problem does this paper attempt to address?